Adenocarcinoma of the Rectum Recruiting Phase 1 Trials for Oxaliplatin (DB00526)

IndicationStatusPhase
DBCOND0028688 (Adenocarcinoma of the Rectum)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02641691Non-Operative Radiation Management of Adenocarcinoma of the Lower RectumTreatment